ZIP6 expression levels were associated with good outcome for breast cancer patients, however, the ZIP6 antibody epitope (residues 140–155) would be predicted to recognize endoplasmic-reticulum-located ZIP6 [41]. Here, SLC39A6 is linked to breast carcinoma.